Literature DB >> 52767

Positive end-expiratory pressure in weaning patients from controlled ventilation. A prospective randomised trial.

T W Feeley, R Saumarez, J M Klick, T G McNabb, J J Skillman.   

Abstract

Twenty-five patients in acute respiratory failure were randomised to receive either 5 cm of positive end-expiratory pressure (P.E.E.P.) or no-P.E.E.P. while weaning from controlled ventilation. The use of P.E.E.P. resulted in a significant reduction in the increase in alveolar-arterial oxygen tension gradient (AaDO21) which occurred in the group of patients who were converted from controlled ventilation to spontaneous ventilation without P.E.E.P. Patients who weaned without P.E.E.P. had a mean increase in AaDO21 of 102+/-35 mm Hg S.E. while those who weaned with P.E.E.P. had a mean increase of only 10+/-22 mm Hg (P less than 0-03). The use of P.E.E.P. was also associated with a significant improvement in the vital capacity and the maximum inspiratory force. Patients who weaned with P.E.E.P. had an increase in vital capacity of 258+/-108 ml (P less than 0-05) and an increase in inspiratory force of -15+/-5 cm H2O (P less than 0-01), while patients who weaned without P.E.E.P. did not have significant changes in these measurements. The use of P.E.E.P. during weaning may be helpful in patients who fail to wean because of the development of hypoxaemia due to rapid alveolar collapse, since P.E.E.P. appears to minimise the increase in intrapulmonary right-to-left shunt which normally occurs during weaning from controlled ventilation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 52767     DOI: 10.1016/s0140-6736(75)90719-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

1.  Respiratory failure and mechanical ventilation: pathophysiology and methods of promoting weaning.

Authors:  J P Karpel; T K Aldrich
Journal:  Lung       Date:  1986       Impact factor: 2.584

2.  Severe chronic intra-abdominal sepsis: a report of 3 cases and a review of patient management.

Authors:  C H Browne; E Gross; G C Hanson; A K Webb
Journal:  Intensive Care Med       Date:  1978-04       Impact factor: 17.440

3.  Weaning patients from mechanical ventilation.

Authors:  D R Browne
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

4.  The management of the pulmonary aspiration syndrome.

Authors:  C H Browne; H E Chew; E Clark; J M Edwards; G C Hanson; K D Roberts
Journal:  Intensive Care Med       Date:  1977-12       Impact factor: 17.440

5.  Associations between positive end-expiratory pressure and outcome of patients without ARDS at onset of ventilation: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Ary Serpa Neto; Roberto Rabello Filho; Thomas Cherpanath; Rogier Determann; Dave A Dongelmans; Frederique Paulus; Pieter Roel Tuinman; Paolo Pelosi; Marcelo Gama de Abreu; Marcus J Schultz
Journal:  Ann Intensive Care       Date:  2016-11-03       Impact factor: 6.925

Review 6.  Trials directly comparing alternative spontaneous breathing trial techniques: a systematic review and meta-analysis.

Authors:  Karen E A Burns; Ibrahim Soliman; Neill K J Adhikari; Amer Zwein; Jessica T Y Wong; Carolina Gomez-Builes; Jose Augusto Pellegrini; Lu Chen; Nuttapol Rittayamai; Michael Sklar; Laurent J Brochard; Jan O Friedrich
Journal:  Crit Care       Date:  2017-06-01       Impact factor: 9.097

7.  RELAx - REstricted versus Liberal positive end-expiratory pressure in patients without ARDS: protocol for a randomized controlled trial.

Authors:  Anna Geke Algera; Luigi Pisani; Dennis C J Bergmans; Sylvia den Boer; Corianne A J de Borgie; Frank H Bosch; Karina Bruin; Thomas G Cherpanath; Rogier M Determann; Arjen M Dondorp; Dave A Dongelmans; Henrik Endeman; Jasper J Haringman; Janneke Horn; Nicole P Juffermans; David M van Meenen; Nardo J van der Meer; Maruschka P Merkus; Hazra S Moeniralam; Ilse Purmer; Pieter Roel Tuinman; Mathilde Slabbekoorn; Peter E Spronk; Alexander P J Vlaar; Marcelo Gama de Abreu; Paolo Pelosi; Ary Serpa Neto; Marcus J Schultz; Frederique Paulus
Journal:  Trials       Date:  2018-05-09       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.